NAYA Biosciences announces strategic decision to separate fertility and oncology

The company states: “INVO Fertility, formerly known as NAYA Biosciences (NAYA), announced its decision to separate its fertility and oncology operations. This strategic decision to separate its two principal focus areas is expected to enable both businesses to maximize shareholder value. In connection with the planned separation, the Company has been renamed to “INVO Fertility, Inc.” effective Monday, April 14, 2025, and its Nasdaq ticker symbol will be changed to “IVF” as soon as practicable. The Company will provide additional information on the expected date for the new symbol to go effective. With this separation, the Company returns to its previous, exclusive focus on the fertility marketplace – the establishment, acquisition and operation of new fertility clinics and the distribution of the Company’s FDA-cleared INVOcell device.”